Pyronaridine in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)

NCT05291390 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)
Acute Lymphoblastic Leukemia (ALL)

Interventions

DRUG: Pyronaridine Tetraphosphate

Sponsor

Armaceutica, Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]